KWMG LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-46
Closed -$3K 240
2019
Q1
$3K Sell
46
-211
-82% -$14K ﹤0.01% 402
2018
Q4
$16K Sell
257
-66
-20% -$4.61K ﹤0.01% 243
2018
Q3
$25K Sell
323
-106
-25% -$8.01K 0.01% 207
2018
Q2
$30K Sell
429
-20,768
-98% -$1.47M 0.01% 197
2018
Q1
$1.6M Sell
21,197
-5,214
-20% -$414K 0.47% 73
2017
Q4
$1.89M Buy
26,411
+1,431
+6% +$109K 0.57% 58
2017
Q3
$2.02M Buy
24,980
+1,005
+4% +$76.8K 0.67% 37
2017
Q2
$1.7M Buy
23,975
+2,290
+11% +$152K 0.6% 47
2017
Q1
$1.47M Buy
+21,685
New +$1.52M 0.57% 63

Other funds holding GILD

KWMG LLC's GILD Position: Q2 2019 in Review

KWMG LLC sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 46 shares — an estimated $3K sold.

KWMG LLC first reported a position in GILD in Q1 2017 and held it in 9 quarters. The position peaked at $2.02M in Q3 2017. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • KWMG LLC reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • KWMG LLC sold 46 Gilead Sciences shares in Q2 2019, an estimated $3K.
  • KWMG LLC first reported a position in Gilead Sciences in Q1 2017 and held it in 9 quarters.
  • KWMG LLC's Gilead Sciences position peaked at $2.02M in Q3 2017.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on KWMG LLC's 13F filing for Q2 2019, filed 10 Jul 2019.